ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
TrippBio receives Notice of Allowance from the U.S. Patent Office for Therapeutic Treatment of COVID-19 Infections
July 16, 2021TrippBio, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application No. 16/875,487, and the European Patent Office (EPO) has issued a favorable opinion in a counterpart European application.
Pharma Sources Insight January 2025
